This application claims priority to Korean Patent Application No. 10-2009-23156, filed on 2009 Mar. 18, and all the benefits accruing therefrom under 35 U.S.C. §119, the contents of which in its entirety are herein incorporated by reference.
1. Field
Embodiments of the disclosure relate to an apparatus for detecting brain conditions.
2. Description of the Related Art
In the diagnosis of cerebrovascular diseases such as epilepsy, stroke or cerebral infarction and degenerative brain diseases such as dementia or Parkinson's disease, brain activities or cerebral oxygen saturation or cerebral blood parameters (hemoglobin concentrations, blood volume, blood flow, cerebral metabolic rate of oxygen, etc) may be used as indices. By continuously monitoring the brain activities or cerebral oxygen saturation or cerebral blood parameters, acutely occurring events may be detected or prevented. As a consequence, death or brain death caused by brain diseases may be reduced or prevented.
An existing apparatus used to measure cerebral oxygen saturation does so using near infrared by mounting an optical sensor on the scalp. The apparatus irradiates light to the brain passing through the scalp and the skull, and detects the light as it is scattered from the brain and returns passing through the scalp and the skull. However, when such an apparatus is used, most of the near infrared light remains in the scalp or the skull, not passing through the brain. As a result, the intracranial apparatus as we suggest in this claim, collects the information of brain exclusively.
The embodiments of this disclosure may provide an apparatus capable of detecting brain conditions such as blood flow rate, oxygen saturation, etc. with improved accuracy and reliability as embedded at a location adjacent to the brain of humans or animals.
In an aspect, the apparatus for detecting brain conditions may include: a layer which is located adjacent to the brain; a light source which is formed on the layer and irradiates light to the brain; and an optical sensor which is formed on the layer and detects the light scattered from the brain.
The apparatus for detecting brain conditions according to the embodiments of the disclosure is capable of detecting brain conditions at a location relatively adjacent to the brain, and thus may improve accuracy and reliability of detection. The apparatus for detecting brain conditions may be used to detect brain conditions such as blood flow rate, oxygen saturation, etc., and thus may immediately cope with emergency situations. Further, it may be employed in various applications including neurosurgery, surgery, internal medicine, emergency medicine, or the like since monitoring of brain activities is possible. In addition, since it has a relatively small size and weight in addition to its flexibility, it may minimize damage to the brain tissue.
The above and other aspects, features and advantages of the disclosed exemplary embodiments will be more apparent from the following detailed description taken in conjunction with the accompanying drawings in which:
a to 3c are schematic cross-sectional views of apparatuses for detecting brain conditions according to embodiments, in which a light source and an optical sensor are integrated in a layer;
a to 4d schematically show the arrangement of light sources and optical sensors in apparatuses for detecting brain conditions according to embodiments;
Exemplary embodiments now will be described more fully hereinafter with reference to the accompanying drawings, in which exemplary embodiments are shown. This disclosure may, however, be embodied in many different forms and should not be construed as limited to the exemplary embodiments set forth therein. Rather, these exemplary embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of this disclosure to those skilled in the art. In the description, details of well-known features and techniques may be omitted to avoid unnecessarily obscuring the presented embodiments.
The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of this disclosure. As used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. Furthermore, the use of the terms a, an, etc. does not denote a limitation of quantity, but rather denotes the presence of at least one of the referenced item. The use of the terms “first”, “second”, and the like does not imply any particular order, but they are included to identify individual elements. Moreover, the use of the terms first, second, etc. does not denote any order or importance, but rather the terms first, second, etc. are used to distinguish one element from another. It will be further understood that the terms “comprises” and/or “comprising”, or “includes” and/or “including” when used in this specification, specify the presence of stated features, regions, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, regions, integers, steps, operations, elements, components, and/or groups thereof.
Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and the present disclosure, and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
In the drawings, like reference numerals in the drawings denote like elements. The shape, size and regions, and the like, of the drawing may be exaggerated for clarity.
Referring to
The layer 10 may be prepared to have a size and thickness appropriate for insertion into a living body by means of nanofabrication. For example, the layer 10 may have a thickness t 300 μm or smaller, preferably 30 μm or smaller. The layer 10 may be made of an organic material or an inorganic material. Further, the layer 10 may be made of a flexible material so that it may be bent depending on the brain's motion. For example, the layer 10 may be made of polyimide, polydimethylsiloxane (PDMS), or other suitable material.
A light source 20 and an optical sensor 30 may be formed on the layer 10. The light source 20 and the optical sensor 30 may be located on the surface of the layer 10 or may be embedded in the layer 10 without being exposed on the surface. The light source 20 is a device for emitting light. The light emitted from the light source 20 may be irradiated to the brain. The light source 20 may include an appropriate light-emitting element such as, for example, an organic light-emitting element or an inorganic light-emitting element. Further, the light source 20 may include a device capable of irradiating near infrared light.
In an embodiment, the light source 20 may include a device capable of irradiating a plurality of lights with different wavelengths. For example, the light source 20 may be capable of irradiating a first light with a wavelength from about 650 nm to about 800 nm and a second light with a wavelength from about 800 nm to about 900 nm at the same time.
The light emitted from the light source 20 may be irradiated into the brain passing through the surface of the brain. The light irradiated into the brain is scattered. All or part of the scattered light may return out of the brain.
As the light irradiated to the brain by the light source 20 is scattered from the brain and returns, the optical sensor 30 may detect the returning light. The optical sensor 30 may include a device capable of detecting the light from the light source 20 according to a type of the light source 20. For example, the optical sensor 30 may include a micro photodiode.
In an embodiment, the light source 20 and the optical sensor 30 may be plural, respectively. Further, a plurality of light sources 20 and optical sensors 30 may be arranged in the layer 10 in arrays. In this case, each optical sensor 30 may detect light from one or more adjacent light source(s) 20. Further, a plurality of light sources 20 may irradiate light with a time difference in a time multiplex mode.
By detecting the light emitted from the light source 20 and scattered from the brain using the optical sensor 30, brain conditions such as blood flow rate, oxygen saturation, etc. may be detected. For example, in the near infrared region, the brain tissue has a relatively low absorption rate μa and a relatively high scattering rate μs. The intensity ψ of the light scattered from the brain under such a physical condition satisfies Equation 1.
In Equation 1, S0(r, t) is a function of the light from the light source 20, for a spatial vector r and time t.
According to the modified Beer-Lambert law, the absorption coefficient by a medium for light propagation is proportional to the sum of products of concentration of light-absorbing molecule and the extinct coefficient of the molecule. The absorption coefficient is dependent on the wavelength of light; hence application of multiple wavelengths of light is capable of quantifying the concentrations of different types of absorbing molecule with known absorption spectrum. Since hemoglobin is the main light-absorbing species in the living body tissue in near infrared range, the absorption rate μa in Equation 1 is approximated by summation of absorption due to hemoglobin molecules. Since the absorption spectra of hemoglobin molecules are different depending on its oxygenation states, the absorption rate μa is expressed as
In Equation 2, by the modified Beer-Lambert law, where ελ is the extinct coefficient of the corresponding molecule at wavelength λ, c is the concentration of the light absorbing molecule, and [ ] denotes the concentration of the molecule. That is,
[O2Hb] and [HHb] are the concentrations of oxyhemoglobin and deoxyhemoglobin, respectively, and ελO
If the light source 20 emits two or more lights with different wavelengths, the solutions of Equation 2 can be found. With the calculated concentrations of oxyhemoglobin and deoxyhemoglobin in the brain, the oxygen saturation StO2 of the brain can be calculated by Equation 3.
The wavelengths of the lights irradiated by the light source 20 may be determined based on the absorption spectrum of hemoglobin. For example, by employing two or more wavelengths at which the difference in absorption rates of oxyhemoglobin and deoxyhemoglobin is relatively large, the concentrations of oxyhemoglobin and deoxyhemoglobin may be obtained with a relatively smaller error.
Referring to
As described above, the concentrations of oxyhemoglobin and deoxyhemoglobin may be determined based on the light detected by the optical sensor 30, and the oxygen saturation of the brain may be determined based on the concentrations of oxyhemoglobin and deoxyhemoglobin. The sum of the concentrations of oxyhemoglobin and deoxyhemoglobin is the total hemoglobin concentration, and is proportional to the blood flow rate. Accordingly, the apparatus for detecting brain conditions according to an embodiment may be used to detect brain conditions, including the blood flow rate.
The light source 20 and the optical sensor 30 may be integrated into the layer 10 by means of nanofabrication. In this regard, the light source 20 and the optical sensor 30 may have a nanometer scale size, so that the weight of the apparatus for detecting brain conditions is 10 mg or less.
Since the light source 20 and the optical sensor 30 are integrated into the layer 10 by means of nanofabrication, the apparatus for detecting brain conditions may be manufactured into a size appropriate for insertion into a living body. Because the apparatus for detecting brain conditions may be embedded into a location relatively adjacent to the brain, the accuracy and reliability of detection may be improved. Furthermore, the effect of the apparatus for detecting brain conditions on the living body tissue may be minimized, and unwanted movement of the devices of the apparatus caused by the movement of the brain may be minimized.
In an embodiment, an electrode 40 may be formed in the layer 10. The electrode 40 may be in contact with the brain and may serve to detect electrical signals from brain cells. Like the light source 20 and the optical sensor 30, the electrode 40 may also be plural. Further, a plurality of electrodes 40 may be arranged in the layer 10 in arrays. By analyzing the electrical signals detected by a plurality of electrodes 40, brain activities may be monitored by means of electrocorticography (ECoG).
a to 3c are schematic cross-sectional views of apparatuses for detecting brain conditions according to embodiments, in which a light source and an optical sensor are integrated in a layer.
a to 3c are figures for explaining the location of light sources 20, 21, 22, optical sensors 30, 31, 32, an electrode 40 and a connector 100 in a layer 10. The order of arrangement of the light sources 20, 21, 22, the optical sensors 30, 31, 32, the electrode 40 and the connector 100 and the shapes thereof depicted in
Referring to
In an embodiment, the light source 20 and the optical sensor 30 may be located on an upper surface 11 of the layer 10, and the electrode 40 may be located to be exposed on a lower surface 12 of the layer 10. For example, when the apparatus for detecting brain conditions is embedded beneath the skull, the upper surface 11 of the layer 10 may be adjacent to the skull, and the lower surface 12 may be adjacent to the brain. The light source 20 and the optical sensor 30 located on the upper surface 11 of the layer 10 may irradiate light to the brain through the layer 10 or detect the light scattered from the brain. The electrode 40 may be located on the lower surface 12 of the layer 10 so that it may be in contact with the brain and detect electrical signals from the brain.
The light source 20 may include input and output terminals 200, 205 for transmitting electrical signals. Each terminal 200, 205 may be formed from one or more conductive material(s). The shape of the terminals 200, 205 depicted in
Referring to
Referring to
In the embodiments of
a to 4d schematically show the arrangement of light sources 20 and optical sensors 30 in apparatuses for detecting brain conditions according to embodiments.
Referring to
Referring to
Referring to
Referring to
The arrangements of light sources 20 and optical sensors 30 described referring to
An apparatus for detecting brain conditions according to an embodiment may include a plurality of light sources. The plurality of light sources may be grouped into n groups. Each group may include at least one light source, and each group may include the same or different number of light source(s). The n light source groups may operate in a time multiplex mode.
The power waveforms L1, L2, . . . , Ln may be designed to have a high level at different time, with a time difference. As a result, the n light source groups may emit light at different times. Since each light source emits light at different time, by controlling the operation time of the optical sensor corresponding to specific light sources depending on the light emission time of the light sources, it may be possible to allow each optical sensor to detect lights from specific adjacent light sources only.
The drive waveform of
Referring to
The apparatus 1 for detecting brain conditions may be optically and/or electrically connected to an amplifier 50 and a controller 60 outside the human body. The amplifier 50 may amplify the light and electrical signals detected by the apparatus 1 for detecting brain conditions. By amplifying the magnitude of the light and electrical signals using the amplifier 50, detection of brain conditions may become easier.
The controller 60 may receive the light and electrical signals amplified by the amplifier 50. Using the received light or electrical signals, the controller 60 may detect brain conditions such as blood flow rate, oxygen saturation, or the like. The change in the intensity of the received light is proportional to the change in the light absorption coefficient by the brain. The change in oxygen saturation or blood flow rate may be determined using Equations 1 to 3.
In
While the exemplary embodiments have been shown and described, it will be understood by those skilled in the art that various changes in form and details may be made thereto without departing from the spirit and scope of this disclosure as defined by the appended claims.
In addition, many modifications can be made to adapt a particular situation or material to the teachings of this disclosure without departing from the essential scope thereof. Therefore, it is intended that this disclosure not be limited to the particular exemplary embodiments disclosed as the best mode contemplated for carrying out this disclosure, but that this disclosure will include all embodiments falling within the scope of the appended claims.
Number | Date | Country | Kind |
---|---|---|---|
10-2009-0023156 | Mar 2009 | KR | national |